An in-depth look to OPTIPHARM. CO., LTD operating, investing, and financing activities

153710 free cash flow for Q2 24 is 140.43 M KRW. For 2023, 153710 free cash flow was -3.39 B KRW and operating cash flow was -1.72 B KRW.